ConductScience.org, home

Paper · 34856752

Aldosterone is a possible new stimulating factor for promoting vascular calcification.

Zhang X and 6 others. Front Biosci (Landmark Ed), 2021. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Aldosterone is a possible new stimulating factor for promoting vascular calcification. Papers, record 34856752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34856752

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aldosterone is a possible new stimulating factor for promoting vascular calcification.
PubMed
Journal
Front Biosci (Landmark Ed)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2022-01-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang XXusheng
2Zhou XXiaoou
3Huang ZZhanjun
4Fan XXiaorong
5Tan XXiaoqing
6Lu CChengzhi
7Yang JJianshe

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AldosteroneMajor topic
Vascular CalcificationMajor topic
Animals
Aorta
Rats
Renin-Angiotensin System
Spironolactone

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42,636,441Defining the potential role of the mineralocorticoid receptor in musculoskeletal health and bone crosstalk with other tissues.J Endocrinol2026https://conductscience.org/library/papers/42636441PubMed
41,984,736Mineralocorticoid Receptor Antagonists in Dialysis.Am J Nephrol2026https://conductscience.org/library/papers/41984736PubMed
41,593,503Rat models for arterial calcification associated with chronic kidney disease: a systematic review and meta-analysis.BMC Cardiovasc Disord2026https://conductscience.org/library/papers/41593503PubMed
40,309,587Nutritional status of elderly hypertensive patients and its relation to the occurrence of cognitive impairment.World J Psychiatry2025https://conductscience.org/library/papers/40309587PubMed
39,312,016Aldosterone promotes calcification of vascular smooth muscle cells in mice through the AIF-1/Wnt/β-catenin signaling pathway.Int Urol Nephrol2025https://conductscience.org/library/papers/39312016PubMed
39,125,667Epigenetic Regulation of the Renin-Angiotensin-Aldosterone System in Hypertension.Int J Mol Sci2024https://conductscience.org/library/papers/39125667PubMed
39,077,075Obstructive Sleep Apnea and Hypertensive Heart Disease: From Pathophysiology to Therapeutics.Rev Cardiovasc Med2023https://conductscience.org/library/papers/39077075PubMed
37,237,507AIF1: Function and Connection with Inflammatory Diseases.Biology (Basel)2023https://conductscience.org/library/papers/37237507PubMed
36,687,666Mineralocorticoid receptor antagonist treatment improved arterial stiffness in patients with primary aldosteronism: a cohort study compared with adrenalectomy.Ther Adv Chronic Dis2023https://conductscience.org/library/papers/36687666PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34856752

GET https://conductscience.org/api/papers/v1/34856752/authors